TL1A as a therapeutic target in inflammatory bowel disease

被引：10
|
作者：
Kokkotis, Georgios [1 ]
Bamias, Giorgos [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sotiria Hosp, Dept Internal Med 3, GI Unit, Athens, Greece
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2022年 / 18卷 / 06期
关键词：
IBD; intervention; mucosal immunity; TL1A; TNFSF15; TNF-LIKE LIGAND; CYTOKINE; LYMPHOCYTES; EXPRESSION; CELL; 1A;
D O I：
10.1080/1744666X.2022.2074401
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：551 / 555
页数：5
相关论文
共 50 条
  • [11] IMMUNOLOGY TL1A in the inflammatory network in autoimmune diseases
    Bayry, Jagadeesh
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (02) : 67 - 68
  • [12] The TL1A inhibitors in IBD: what's in the pot?
    Lusetti, F.
    Bezzio, C.
    De Bernardi, A.
    Dota, M.
    Manes, G.
    Saibeni, S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (01) : 15 - 25
  • [13] Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review
    Xu, Wang-Dong
    Li, Rong
    Huang, An-Fang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [14] Keeping the Bowel Regular: The Emerging Role of Treg as a Therapeutic Target in Inflammatory Bowel Disease
    Gibson, David J.
    Ryan, Elizabeth J.
    Doherty, Glen A.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (12) : 2716 - 2724
  • [15] The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
    Verma, Ankit
    Pittala, Srinivas
    Alhozeel, Belal
    Shteinfer-Kuzmine, Anna
    Ohana, Ehud
    Gupta, Rajeev
    Chung, Jay H.
    Shoshan-Barmatz, Varda
    MOLECULAR THERAPY, 2022, 30 (02) : 726 - 744
  • [16] The Role of TL1A and DR3 in Autoimmune and Inflammatory Diseases
    Aiba, Yoshihiro
    Nakamura, Minoru
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [17] Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease
    McAllister, Milly J.
    Hall, Rebecca
    Whelan, Robert J.
    Fischer, Lena J.
    Chuah, Cher S.
    Cartlidge, Peter D.
    Drury, Broc
    Rutherford, Duncan G.
    Duffin, Rodger M.
    Cartwright, Jennifer A.
    Dorward, David A.
    Rossi, Adriano G.
    Ho, Gwo-tzer
    CROHNS & COLITIS 360, 2024, 6 (01)
  • [18] Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease
    Yang, Wen-sheng
    Wang, Jing-lin
    Wu, Wei
    Wang, Guang-fei
    Yan, Jun
    Liu, Qing
    Wu, Xiao-yan
    Zhou, Qing-tong
    Yang, De-hua
    Wang, Ming-Wei
    Li, Zhi-ping
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (01) : 19 - 31
  • [19] Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease
    Wen-sheng Yang
    Jing-lin Wang
    Wei Wu
    Guang-fei Wang
    Jun Yan
    Qing Liu
    Xiao-yan Wu
    Qing-tong Zhou
    De-hua Yang
    Ming-Wei Wang
    Zhi-ping Li
    Acta Pharmacologica Sinica, 2023, 44 : 19 - 31
  • [20] Treat to Target in Inflammatory Bowel Disease
    Peter Bossuyt
    Séverine Vermeire
    Current Treatment Options in Gastroenterology, 2016, 14 (1) : 61 - 72
12345